The antigenic specificity of antibody-dependent plaque enhancement (ADPE) on the macrophage cell line P388D1 has been investigated using viruses in the flavivirus and alphavirus genera. Whereas ADPE detected group-specific antigenic determinants in the flaviviruses, narrower specificity (type and subgroup) was seen with alphaviruses. ADPE titres correlated well with haemagglutination inhibition titres.
INTRODUCTION
A highly sensitive assay for antiviral antibody based upon plaque enhancement in the macrophage cell line P388D 1 has been described previously (Peiris & Porterfield, 1981) . The mechanism of antibody-dependent plaque enhancement (ADPE) has been shown to be dependent upon Fc receptor function. Here, the ADPE asay has been used to study viruses in two genera, alphavirus and flavivirus, within the family Togaviridae. With flaviviruses, the phenomenon of ADPE is broadly group-specific, a given virus being enhanced both by antisera against closely related and against distantly related flaviviruses. By contrast, enhancement of alphaviruses shows more restricted specificity, with only very limited, subgroup cross-reactivity. Antisera against flaviviruses do not enhance alphaviruses, and vice versa.
METHODS
Viruses, cells and media. These have been described elsewhere (Peiris & Porterfield, 1981) . Preparation of antisera. Rabbit antisera were prepared as described by Madrid & Porterfield (1974) . Usually, sera collected 28 days after a single intravenous inoculation of virus were satisfactory, but with some viruses, 3 or 5 doses were necessary to produce acceptable neutralizing antibody levels in 28 day bleedings. Antisera against purified E 1 and E2 envelope antigens of Western equine encephalitis virus (WEEV) were kindly provided by Dr D. W. Trent (Trent & Grant 1980) , and a potent mouse ascitic fluid against Getah virus was supplied by Dr E. A. Gould.
Antibody determinations. Haemagglutination inhibition (HI) titres were determined by standard procedures (Clarke & Casals, 1958) . Plaque neutralization tests (NT) were carried out by the method of Madrid & Porterfield (1974) . ADPE titres were determined on the basis of the highest dilution of serum that gave at least threefold enhancement of plaque numbers (Peiris & Porterfield, 1981) . Fig. 1 shows the antibody response of a rabbit following a single intravenous inoculation with approx. 107 p.f.u, of West Nile virus (WNV), as measured by HI, NT and ADPE assays. Antibody detectable by HI was present at a dilution of 1 : 10 on day 4, rising to peak values of 1 : 1280 on days 14 to 28. Neutralizing antibody was not detectable before day 14, and reached a plateau at a titre of 1:40 by day 28. No antibody was detectable by ADPE at day 4, but by day 7 the antibody titre exceeded 5 loglo and remained high for the duration of the experiment.
RESULTS

Cross-reactivity within the flaviviruses
The same three WNV antibody assays were next applied to sera collected from rabbits which had been immunized with 25 other flaviviruses; most were 28 day bleedings, but six were sampled on day 21, and four on day 14. The results are presented in Table 1 , which also contains homologous neutralizing antibody levels for the respective immunizing flaviviruses. The expected cross-reactivity between flaviviruses was detected by HI tests, highest titres being seen with antisera against viruses such as Japanese encephalitis and Murray Valley encephalitis, which are in the same subgroup as WNV (Madrid & Porterfield, 1974) . Cross-reactivity in NT tests occurred mainly within the WNV subgroup. Unexpectedly • high cross-reactions with Spondweni and Uganda S antisera in HI and NT tests observed, are probably attributable to the use of Freund's adjuvant in these two rabbits. ADPE titres of different flavivirus antisera ranged from 1/10 to 1/10000. However, the maximal magnitude of plaque enhancement (20-to 40-fold) was comparable for different antisera. Fig. 2 shows a good correlation (correlation coefficient = 0.82; P ~ 0.001) between HI and ADPE titres irrespective of whether or not the antisera were prepared against flaviviruses within the WNV subgroup. There is a poorer, although significant, correlation between NT and ADPE titres (Fig. 3 ) (correlation coefficient = 0.6; P < 0.01). Fig. 4 shows no correlation between ADPE titres to WNV and homologous NT titres measured against respective viruses used to induce the antisera (correlation coefficient = 0.2; P > 0.1). However, when the two non-conforming sera (both to WNV) are removed from the analysis, significant correlation is seen (correlation coefficient = 0.6; P < 0.01).
Cross-reactivity within the alphaviruses
Sindbis virus and Semliki Forest virus (SFV) showed clear ADPE in P388D 1 cells in the presence of subneutralizing concentrations of homologous antibody. However, in contrast to the flaviviruses, cross-reactivity within the alphaviruses was markedly restricted. Table 2 shows results obtained when serial 10-fold dilutions of different alphavirus antisera, which were of comparable potency, were tested against Sindbis virus. Homologous antibody showed > 20-fold enhancement at 10 -2 and 10 -3 dilutions, with twofold enhancement at 10 -4 dilution. No comparable enhancement of Sindbis virus was seen by antiserum against WEEV, which is known to be antigenically closely related to Sindbis virus, nor with O'nyong-nyong, Chikungunya and SFV antisera. However, WEEV and SFV antisera produced marginal (two-to threefold) enhancement of Sindbis virus at 10 -2 and 10 -3 dilutions. Hyperimmune sera against E1 and E2 glycoproteins of WEEV both showed substantial enhancement of Sindbis virus, although a hyperimmune serum to Getah virus did not. 
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In tests with SFV, homologous anti-SFV antiserum gave approx. 100-fold enhancement at 10 -3 and 10 -4 dilutions and eightfold enhancement at 10 -5 (Table 3 ). An antiserum against the attenuated 774 variant of SFV was active to a titre of 10 -4 (data not shown), but antisera against Chikungunya, O'nyong-nyong, Middelburg and WEE viruses showed little or no enhancement. A hyperimmune Getah antiserum produced only slightly less enhancement than the homologous anti-SFV antiserum. Hyperimmune serum against the purified E1 glycoproteins of WEEV gave only threefold enhancement at 10 -1 and 10 -2 dilutions, whereas the E2 antiserum produced no significant effect.
DISCUSSION
Following immunization of a rabbit with WNV, the appearance of antibodies detected by ADPE more closely followed the pattern of HI than NT responses, except on day 4 when antibodies will be predominantly of the IgM subclass (Westaway et al., 1974) . Since ADPE is dependent upon cells with Fc receptors, and since mouse macrophages lack Fc receptors for pentameric IgM, negative results with such early sera are not unexpected.
Antisera against 26 different flaviviruses all enhanced WNV plaque formation in P388D 1 cells, although the ADPE titres (highest dilution showing threefold or greater enhancement) varied quite widely. Similar findings have also been observed with Uganda S virus (data not shown). These results are in agreement with the work of Halstead et al. (1980) who showed that a range of flavivirus antisera could enhance the replication of dengue virus in human peripheral blood leukocyte preparations. In contrast to the wide variation encountered in repeat tests carried out on primary leukocyte cultures, the macrophage cell line gave results that were highly reproducible, as well as offering far greater technical simplicity. It may be noted that the only flavivirus antiserum (against Spondweni virus) which failed to enhance dengue virus replication in human cells gave definite enhancement of WNV when tested in P388D1 cells. The reproducibility of the P388D1 assays is reflected in the good correlation between HI and ADPE titres to WNV. There exists a closer parallel between ADPE and HI titres in contrast to PRNT, as is shown in Figl 1, 2 and 3. The possibility that antigenic determinants responsible for antibody-mediated neutralization and enhancement of virus infectivity are distinguishable has been explored through the production and testing of monoclonal antibodies against WNV, with results that are reported elsewhere (Peiris et al., 1982) .
In contrast to the broad cross-reactivity shown by ADPE assays within the flaviviruses, cross-reactivity within the alphaviruses is markedly narrower. Only homologous antisera or hyperimmune antisera against closely related Viruses (e.g. SFV and Getah virus; Sindbis virus and WEEV) produced enhancement of any appreciable magnitude, although weaker (two-to threefold) enhancement was occasionally seen with other heterologous antisera.
Whereas flaviviruses have only a single envelope glycoprotein, alphaviruses have two (El and E2) with a third glycoprotein (E3) in SFV. Antisera to alphavirus E1 and E2 glycoproteins behave differently in neutralization and HI tests (Dalrymple et al., 1976; Trent & Grant, I980) and it therefore seemed possible that such antisera might behave differently in ADPE tests.
Antisera to E1 and E2 glycoproteins of WEEV were made available to us by Dr D. W. Trent. However, WEEV did not produce plaques or cytopathic effect (c.p.e.) in the P388D1 cell line, although a generalized c.p.e, was evident when WEEV was combined with an appropriate dilution of homologous antiserum. Antisera to E1 and E2 glycoproteins both potentiated such a c.p.e. (data not shown). When the same antisera were tested in P388D1 cells against the closely related Sindbis virus, both produced marked plaque enhancement (Table 2 ). When tested against SFV, the WEE E1 and E2 antisera failed to produce good plaque enhancement, although a marginal two-to threefold increase was noted (similar to that seen in some heterologous alphavirus ADPE reactions, as mentioned earlier).
Thus the pattern of ADPE within the alphaviruses seems to be as follows: (i) homologous antisera produce marked (>20-fold) enhancement; (ii) heterologous antisera (not hyperimmune) produce marginal (two-to threefold) or no enhancement; (iii) heterologous hyperimmune antisera produce marked (>20-fold) plaque enhancement when tested with closely related viruses (e.g. Sindbis virus and WEEV; SFV and Getah virus), but not with others.
